CJC 1295


Image Description


Substance

Growth Hormone Releasing


Active Dosage

2mg/vial


Form

10 x 10iu


Category

Injectable


Classification

Peptide


Half Life

6-8 days


Dosage

50-100 mcg. / day


Acne

No


Water Retention

No


HBR

No


Aromatization

No


Hepatoxity

No


Description

CJC 1295 has shown some amazing results as a growth hormone releasing hormone (GHRH) analog. Not only has CJC 1295 shown potential to increase growth hormone and IGF-I secretion and e!ects, but it has been able to do so in very large amounts. CJC 1295 Stimulates Growth Hormone Secretion, and will keep a steady increase of HGH and IGF-1 with no increase in prolactin, leading to fat loss, and increased protein synthesis thereby promoting growth. CJC 1295 is a tetrasubstituted 30-amino acid peptide hormone, primarily functioning as a growth hormone releasing hormone (GHRH) analog. One of the advantages of CJC 1295 over traditional GHRH or rHGH is its ability to bioconjugate with serum albumin, thus increasing its half-life and therapeutic window. It accomplishes this by using protecting groups around the amino acids of GHRH typically susceptible to enzymatic degradation.

About Us

Founded in 2018, Odin Anabolics Pharmaceuticals is a sterile pharmacetuical company that manufactures and markets anabolics for the worldwide healthcare market.

Supplier Verification: www.check-odin.com

Our Contacts

Head Office:
Clementi, Singapore, Asia

Factory:
Queenstown, Singapore, Asia